All In Biotech

Free tool

FAERS Monitor: Stivarga

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 204369 or its brand name (Stivarga, Regorafenib). Reports on generic versions are filed under their own applications.

Reports

11,611

Serious

10,468

90% of reports

Hospitalization

4,066

Death reported

2,373

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use2,080
  • fatigue1,778
  • palmar-plantar erythrodysaesthesia syndrome1,446
  • diarrhoea1,427
  • decreased appetite1,097
  • death1,007
  • asthenia950
  • dysphonia825
  • nausea818
  • pain in extremity774
  • pyrexia757
  • hypertension700
  • weight decreased639
  • vomiting575
  • rash561

Reports by year received

View as table
YearReports
20112
2012119
2013928
2014810
2015886
2016653
20171,019
20181,150
2019980
2020962
2021956
2022870
2023770
2024694
2025567
2026245

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,548 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
palmar-plantar erythrodysaesthesia syndromeSignal1,446119.7113.9159,747
dysphoniaSignal82525.924.219,502
decreased appetiteSignal1,0978.68.17,398
hypertensionSignal7006.05.62,934
pain in extremitySignal7744.84.52,328
astheniaSignal9504.64.32,702
off label useSignal2,0804.34.15,502
weight decreasedSignal6394.23.91,544
fatigueSignal1,7784.14.04,391
diarrhoeaSignal1,4274.03.83,317
pyrexiaSignal7574.03.71,703
rashSignal5612.32.2434
vomitingSignal5752.22.0391
deathSignal1,0072.12.0618
nausea8181.91.8345

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.